Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Vanguard Total Intl Stock Index Inv

Impax Global Opportunities Strategy Comp

Comgest Growth Europe EUR Acc

Harding Loevner International Eq Instl

SWC (CH) IEF Switzerland Ttl Resp GT CHF

Fidelity Series Overseas

EAFE Equity Index Fund F

Allspring Special Mid Cap Value Inst

Allspring Special US Mid Cap Value Eq

BlackRock Mid-Cap Growth Equity Instl

ClearBridge Large Cap Growth A

UBS (CH) IF - Eq CH All ESG NSL I-A-acc

UBS: Global Equity

Vanguard Developed Markets Index Admiral

Vanguard Instl Ttl Intl Stk Mkt Idx TrII

iShares Core MSCI EAFE ETF

T. Rowe Price US Mid-Cap Growth Equity

T. Rowe Price Mid-Cap Growth

UBS(CH)IF Equities CH All NSL I-B-acc

Vanguard Windsor™ II Inv

Vanguard Group Inc

FMR Inc

T. Rowe Price Investment Management,Inc.

Ako Capital Llp

UBS Group AG

Select Equity Group LP

Legal & General Group PLC

Amundi

Bank of America Corp

Brown Brothers Harriman & Co

Mackenzie Investments

Sustainable Growth Advisers, LP

NORGES BANK

UBS Asset Mgmt Americas Inc

Aristotle Capital Management LLC

Harding Loevner L.P.

Zurcher Kantonalbank

Bank of New York Mellon Corp

Vontobel Holding Ltd.

ClearBridge Advisors, LLC

Alcon AG

Mr. F. Michael Ball

Executive Chairman

Mr. David J. Endicott

CEO & Director

Mr. Arthur B. Cummings M.D.

Executive Director

Mr. Timothy C. Stonesifer

Senior VP & CFO

Mr. Ian  Bell

Senior VP & COO

Margaret  Buckley

Chief Accounting Officer

Dr. Franck  Leveiller

SVP of Global Research & Development and Chief Scientific Officer

Mr. Muru  Murugappan

Senior VP and Chief Information & Transformation Officer

Mr. Royce R. Bedward J.D.

Senior VP, General Counsel & Corporate Secretary

Ms. Kimberly  Martin

Senior VP, Chief HR Officer & Corporate Communications

ALC's next earnings is on February 25, 2025 (After Market Close)

ALC's latest dividend is 0.2647 USD on May 14, 2024

Alcon AG (ALC) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Alcon AG (ALC) Earnings Report Date and History | NYSE

ALC's next earnings is on February 25, 2025 (After Market Close)

When is the earnings report for ALC?

ALC Earnings History

ALC's latest dividend is 0.2647 USD on May 14, 2024

ALC Stock Discussion Forum and Message Board

News for NYSE: ALC